BioSpace News Archive

Quest Products, LLC introduces a new nasal filter designed for people interested in protection against the smallest of airborne particles and pollutants. Its unique filtration material is electrostatically charged to better capture microscopic particles and protect people from droplets released during coughing and sneezing

Covectra, a leader in track and trace solutions, today announced ControlTrack, a mobile telehealth medication adherence management solution to connect providers, patients, pharmacies, and other stakeholders in the delivery of healthcare to improve patient outcomes

Susan McGaurn, Pharm.D. to lead Medical Affairs strategy as company advances late-stage research of oteseconazole (VT-1161), aiming to be the first FDA-approved treatment for recurrent vulvovaginal candidiasis DURHAM, N.C.--( BUSINESS WIRE )-- Mycovia Pharmaceuticals, Inc. (“Mycovia”) today announced the appointment of Susan McGaurn, Pharm.D. as Senior Director of Medical Affairs. In her role, Dr. McGaurn will spearhead strategic medical affairs e

RGENIX, Inc., a clinical stage biopharmaceutical company developing first-in-class small molecule and antibody cancer therapeutics, announced today it is presenting an abstract on RGX-104, RGENIX’s lead therapy in development. RGENIX’s abstract, “RGX-104, a first-in-class immunotherapy targeting the liver-X receptor (LXR); Initial results from the phase 1b RGX-104 plus Docetaxel combination dose escalation cohorts” was accepte

Boston-based Laboratory-as-a-Service (LaaS) leader, SmartLabs, today announced the establishment of the Global Launch Program, a world-class life sciences accelerator.

Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune/inflammatory diseases, today presented the design of NEON-1, the first-in-human study of ALPN-202, a first-in-class, conditional CD28 costimulator and dual checkpoint inhibitor, at the

AIVITA Biomedical, Inc., a biotechnology company specializing in innovative cell therapy applications, announced today that updates from ongoing clinical trials in ovarian cancer and glioblastoma were presented as part of the 2020 American Association for Cancer Research (AACR) Virtual Annual Meeting I. The presentation from Daniela Bota, MD, Ph.D., of the University of California, Irvine, and principal investigator

Bi-Flow is first bidirectional femoral arterial cannula validated for 29 days’ use

St. Thomas University has launched the Center for Pandemic, Disaster, and Quarantine Research, designed to track the impact of emerging, expanding, and extended pandemics and disasters on all socio-economic aspects of society..

The U.S. Food and Drug Administration provided an update on its efforts to ensure the availability of alcohol-based sanitizer to help meet the demand for hand sanitizer during the COVID-19 pandemic.